A Pilot Study to Assess the Amnesic Properties of Dexmedetomidine in Pediatric Patients
| Status: | Completed |
|---|---|
| Conditions: | Cognitive Studies |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 4 - 14 |
| Updated: | 3/2/2019 |
| Start Date: | August 2012 |
| End Date: | March 2015 |
The goal of this study is to determine the effects of dexmedetomidine on memory and recall of
children who are receiving dexmedetomidine sedation administered for magnetic resonance
imaging (MRI) studies. Dexmedetomidine is currently the standard drug for sedation for
diagnostic (MRI, computerized tomography (CT) and Nuclear Medicine) radiological studies at
Boston Children's Hospital (BCH). The effect of dexmedetomidine on memory and recall in
children has not been studied.
children who are receiving dexmedetomidine sedation administered for magnetic resonance
imaging (MRI) studies. Dexmedetomidine is currently the standard drug for sedation for
diagnostic (MRI, computerized tomography (CT) and Nuclear Medicine) radiological studies at
Boston Children's Hospital (BCH). The effect of dexmedetomidine on memory and recall in
children has not been studied.
Inclusion Criteria:
- The patient must be between 4 and 14 yrs of age and be undergoing a therapeutic or
diagnostic procedure with or without sedation
- The patient must be able to comprehend and perform the task (naming pictures)
- The patient must have a minimum weight of 8 kg
Exclusion Criteria:
- Allergy to Dexmedetomidine (for those patients requiring sedation)
- Procedure of short duration (< 15 min)
- Pregnancy
- Recent use (within 5 half-lives) of centrally acting medications that could affect
concentration (e.g. diphenhydramine)
We found this trial at
1
site
Boston Children's Hospital Boston Children's Hospital is a 395-bed comprehensive center for pediatric health care....
Click here to add this to my saved trials
